263 related articles for article (PubMed ID: 19248788)
1. The functional role of S/MARs in episomal vectors as defined by the stress-induced destabilization profile of the vector sequences.
Giannakopoulos A; Stavrou EF; Zarkadis I; Zoumbos N; Thrasher AJ; Athanassiadou A
J Mol Biol; 2009 Apr; 387(5):1239-49. PubMed ID: 19248788
[TBL] [Abstract][Full Text] [Related]
2. Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells.
Ren C; Zhao M; Yang X; Li D; Jiang X; Wang L; Shan W; Yang H; Zhou L; Zhou W; Zhang H
Stem Cells; 2006 May; 24(5):1338-47. PubMed ID: 16410388
[TBL] [Abstract][Full Text] [Related]
3. Physiological levels of HBB transgene expression from S/MAR element-based replicating episomal vectors.
Sgourou A; Routledge S; Spathas D; Athanassiadou A; Antoniou MN
J Biotechnol; 2009 Aug; 143(2):85-94. PubMed ID: 19559736
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of Epstein-Barr virus-derived episomal vectors in the murine Sp2/0 myeloma cell line is dependent upon exogenous expression of human EBP2.
Habel ME; Drouin M; Jung D
Biochem Cell Biol; 2004 Jun; 82(3):375-80. PubMed ID: 15181471
[TBL] [Abstract][Full Text] [Related]
5. Shortened nuclear matrix attachment regions are sufficient for replication and maintenance of episomes in mammalian cells.
Wang XY; Zhang X; Wang TY; Jia YL; Xu DH; Yi DD
Mol Biol Cell; 2019 Oct; 30(22):2761-2770. PubMed ID: 31509492
[TBL] [Abstract][Full Text] [Related]
6. Long-term replication of Epstein-Barr virus-derived episomal vectors in the rodent cells.
Mizuguchi H; Hosono T; Hayakawa T
FEBS Lett; 2000 Apr; 472(2-3):173-8. PubMed ID: 10788606
[TBL] [Abstract][Full Text] [Related]
7. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
Wendelburg BJ; Vos JM
Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
[TBL] [Abstract][Full Text] [Related]
8. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
[TBL] [Abstract][Full Text] [Related]
9. Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy.
Mulia GE; Picanço-Castro V; Stavrou EF; Athanassiadou A; Figueiredo ML
Hum Gene Ther; 2021 Oct; 32(19-20):1076-1095. PubMed ID: 34348480
[TBL] [Abstract][Full Text] [Related]
10. Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells.
Belt PB; Groeneveld H; Teubel WJ; van de Putte P; Backendorf C
Gene; 1989 Dec; 84(2):407-17. PubMed ID: 2482230
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells.
Dorigo O; Gil JS; Gallaher SD; Tan BT; Castro MG; Lowenstein PR; Calos MP; Berk AJ
J Virol; 2004 Jun; 78(12):6556-66. PubMed ID: 15163748
[TBL] [Abstract][Full Text] [Related]
12. Non-integrating lentiviral vectors based on the minimal S/MAR sequence retain transgene expression in dividing cells.
Xu Z; Chen F; Zhang L; Lu J; Xu P; Liu G; Xie X; Mu W; Wang Y; Liu D
Sci China Life Sci; 2016 Oct; 59(10):1024-1033. PubMed ID: 27614752
[TBL] [Abstract][Full Text] [Related]
13. MAR characteristic motifs mediate episomal vector in CHO cells.
Lin Y; Li Z; Wang T; Wang X; Wang L; Dong W; Jing C; Yang X
Gene; 2015 Apr; 559(2):137-43. PubMed ID: 25598284
[TBL] [Abstract][Full Text] [Related]
14. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
Deakyne JS; Malecka KA; Messick TE; Lieberman PM
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy progress and prospects: episomally maintained self-replicating systems.
Conese M; Auriche C; Ascenzioni F
Gene Ther; 2004 Dec; 11(24):1735-41. PubMed ID: 15385951
[TBL] [Abstract][Full Text] [Related]
16. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
[TBL] [Abstract][Full Text] [Related]
17. Minicircle performance depending on S/MAR-nuclear matrix interactions.
Broll S; Oumard A; Hahn K; Schambach A; Bode J
J Mol Biol; 2010 Feb; 395(5):950-65. PubMed ID: 20004666
[TBL] [Abstract][Full Text] [Related]
18. An episomally maintained MDR1 gene for gene therapy.
Lee CG; Vieira WD; Pastan I; Gottesman MM
Hum Gene Ther; 2001 May; 12(8):945-53. PubMed ID: 11387059
[TBL] [Abstract][Full Text] [Related]
19. [Progress of EBNA1/oriP-based plasmid applied in gene therapy].
He J; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):507-10. PubMed ID: 16108385
[TBL] [Abstract][Full Text] [Related]
20. Episomal vectors based on S/MAR and the β-globin Replicator, encoding a synthetic transcriptional activator, mediate efficient γ-globin activation in haematopoietic cells.
Stavrou EF; Simantirakis E; Verras M; Barbas C; Vassilopoulos G; Peterson KR; Athanassiadou A
Sci Rep; 2019 Dec; 9(1):19765. PubMed ID: 31874995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
